PICTET ASSET MANAGEMENT LTD - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 113 filers reported holding GW PHARMACEUTICALS PLC in Q3 2015. The put-call ratio across all filers is 2.38 and the average weighting 0.3%.

Quarter-by-quarter ownership
PICTET ASSET MANAGEMENT LTD ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$422,000
-84.2%
24,612
-91.7%
0.00%
-66.7%
Q4 2020$2,678,000
-13.6%
295,872
-30.0%
0.00%
-40.0%
Q3 2020$3,098,000
+12.5%
422,625
+52.2%
0.01%0.0%
Q2 2020$2,755,000
+109.3%
277,724
+53.0%
0.01%
+66.7%
Q1 2020$1,316,000
-45.1%
181,465
-34.2%
0.00%
-25.0%
Q4 2019$2,398,000
-46.7%
275,635
-42.9%
0.00%
-20.0%
Q3 2019$4,498,000
-21.1%
482,676
+18.3%
0.01%
-58.3%
Q2 2019$5,703,000
-15.8%
407,940
-15.7%
0.01%
-20.0%
Q1 2019$6,777,000
+63.7%
484,036
-6.5%
0.02%
+50.0%
Q4 2018$4,141,000
-43.7%
517,666
+4.3%
0.01%
-37.5%
Q3 2018$7,356,000
-87.1%
496,345
+21.5%
0.02%
-88.2%
Q2 2018$57,023,000
+24.9%
408,647
+0.9%
0.14%
+20.4%
Q1 2018$45,653,000
-5.3%
405,192
+11.0%
0.11%
-8.9%
Q4 2017$48,190,000
+33.7%
365,046
+2.8%
0.12%
+21.6%
Q3 2017$36,056,000
+108.5%
355,263
+102.6%
0.10%
+92.5%
Q2 2017$17,292,000
+11.2%
175,352
+36.4%
0.05%
+3.9%
Q1 2017$15,549,000
+96.0%
128,571
+81.1%
0.05%
+75.9%
Q4 2016$7,934,000
+651.3%
70,993
+792.2%
0.03%
+625.0%
Q3 2016$1,056,000
+48.9%
7,9570.0%0.00%
+33.3%
Q2 2016$709,000
-0.3%
7,957
-54.0%
0.00%0.0%
Q1 2016$711,000
-40.8%
17,3090.0%0.00%
-40.0%
Q4 2015$1,202,000
+25.3%
17,309
+64.8%
0.01%
+25.0%
Q3 2015$959,000
-66.2%
10,500
-57.7%
0.00%
-66.7%
Q2 2015$2,840,00024,8000.01%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q3 2015
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 390,000$45,010,0007.31%
Copernicus Capital Management, LLC 2,788$322,0005.02%
Integral Health Asset Management, LLC 72,500$8,367,0002.49%
Parkman Healthcare Partners LLC 81,573$9,414,0002.41%
AdvisorShares Investments LLC 66,317$7,654,0001.78%
Tri Locum Partners LP 40,159$4,635,0001.68%
ETF MANAGERS GROUP, LLC 621,361$71,711,0001.57%
Redmile Group, LLC 815,681$94,138,0001.14%
Redwood Investments, LLC 108,999$12,580,0001.07%
ROOSEVELT INVESTMENT GROUP LLC 127,885$14,759,0001.05%
View complete list of GW PHARMACEUTICALS PLC shareholders